A detailed history of Red Tortoise LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Red Tortoise LLC holds 801 shares of NKTX stock, worth $1,882. This represents 0.0% of its overall portfolio holdings.

Number of Shares
801
Previous 801 -0.0%
Holding current value
$1,882
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$5.59 - $15.71 $586 - $1,649
-105 Reduced 11.59%
801 $8,000
Q3 2023

Nov 02, 2023

BUY
$1.39 - $2.29 $700 - $1,154
504 Added 125.37%
906 $1,000
Q2 2023

Jul 26, 2023

BUY
$2.19 - $5.17 $880 - $2,078
402 New
402 $0
Q4 2022

Feb 01, 2023

BUY
$5.14 - $14.35 $904 - $2,525
176 New
176 $1,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $114M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Red Tortoise LLC Portfolio

Follow Red Tortoise LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Tortoise LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Tortoise LLC with notifications on news.